Forbes William P has filed 66 insider transactions across 2 companies since January 2024.
Most recent transaction: a grant/award of 188315 shares of HERON THERAPEUTICS, INC. /DE/ ($HRTX) on January 30, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | A | Restricted Stock Units | 188315 | $0.00 | 188,315.0000 | 183,362,522 | 9999.99% | 0.10% |
| Jan. 31, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 11695 | $0.00 | 140,332.0000 | 183,362,522 | 7.69% | 0.01% |
| Jan. 31, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 11695 | $0.00 | 181,773.0000 | 183,362,522 | 6.88% | 0.01% |
| Jan. 30, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | A | Performance Stock Units | 188314 | $0.00 | 188,314.0000 | 183,362,522 | 9999.99% | 0.10% |
| Jan. 19, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3875 | $0.00 | 170,078.0000 | 183,362,522 | 2.33% | 0.00% |
| Jan. 19, 2026 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3875 | $0.00 | 30,994.0000 | 183,362,522 | 11.11% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 2000 | $0.00 | 2,000.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 2000 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 1500 | $0.00 | 1,500.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 1500 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 1250 | $0.00 | 1,250.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 1250 | $0.00 | 1,250.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 1250 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 3750 | $0.00 | 3,750.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 3750 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 2250 | $0.00 | 2,250.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 2250 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 400 | $0.00 | 400.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 1250 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 1250 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 1250 | $0.00 | 1,250.0000 | 92,794,777 | 9999.99% | 0.00% |
| Nov. 4, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 400 | $0.00 | 0.0000 | 92,794,777 | 100.00% | 0.00% |
| Oct. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 11694 | $0.00 | 152,027.0000 | 183,362,522 | 7.14% | 0.01% |
| Oct. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 11694 | $0.00 | 166,203.0000 | 183,362,522 | 7.57% | 0.01% |
| Oct. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3874 | $0.00 | 34,869.0000 | 152,329,588 | 10.00% | 0.00% |
| Oct. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3874 | $0.00 | 154,509.0000 | 152,329,588 | 2.57% | 0.00% |
| July 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 11695 | $0.00 | 163,721.0000 | 152,329,588 | 6.67% | 0.01% |
| July 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 11695 | $0.00 | 150,635.0000 | 152,329,588 | 8.42% | 0.01% |
| July 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3874 | $0.00 | 38,743.0000 | 152,329,588 | 9.09% | 0.00% |
| July 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3874 | $0.00 | 138,940.0000 | 152,329,588 | 2.87% | 0.00% |
| June 6, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 12500 | $0.00 | 25,000.0000 | 152,329,588 | 33.33% | 0.01% |
| June 6, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 12500 | $0.00 | 135,066.0000 | 152,329,588 | 10.20% | 0.01% |
| April 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 11694 | $0.00 | 175,416.0000 | 152,329,588 | 6.25% | 0.01% |
| April 30, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 11694 | $0.00 | 122,566.0000 | 152,329,588 | 10.55% | 0.01% |
| April 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3875 | $0.00 | 42,617.0000 | 152,329,588 | 8.33% | 0.00% |
| April 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3875 | $0.00 | 110,872.0000 | 152,329,588 | 3.62% | 0.00% |
| March 26, 2025 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 75000 | $0.00 | 75,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | A | Employee Stock Option (Right to Buy) | 374220 | $0.00 | 374,220.0000 | 0 | 9999.99% | 0.00% |
| Jan. 31, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | A | Restricted Stock Units | 187110 | $0.00 | 187,110.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3874 | $0.00 | 106,997.0000 | 0 | 3.76% | 0.00% |
| Jan. 19, 2025 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3874 | $0.00 | 46,492.0000 | 0 | 7.69% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 8000 | $0.00 | 8,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 40000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 30000 | $0.00 | 30,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 30000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 25000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 8000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | D | Stock Options (Right to buy) | 45000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 22, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Options (Right to buy) | 40000 | $0.00 | 40,000.0000 | 0 | 9999.99% | 0.00% |
| Oct. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3874 | $0.00 | 103,123.0000 | 0 | 3.90% | 0.00% |
| Oct. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3874 | $0.00 | 50,366.0000 | 0 | 7.14% | 0.00% |
| July 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3875 | $0.00 | 99,249.0000 | 0 | 4.06% | 0.00% |
| July 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3875 | $0.00 | 54,240.0000 | 0 | 6.67% | 0.00% |
| June 6, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 12500 | $0.00 | 95,374.0000 | 0 | 15.08% | 0.00% |
| June 6, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 12500 | $0.00 | 37,500.0000 | 0 | 25.00% | 0.00% |
| April 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Common Stock | 3874 | $0.00 | 82,874.0000 | 0 | 4.90% | 0.00% |
| April 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | M | Restricted Stock Units | 3874 | $0.00 | 58,115.0000 | 0 | 6.25% | 0.00% |
| March 20, 2024 | Beyond Air, Inc. | $XAIR | Forbes William P | Director | A | Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | A | Restricted Stock Units | 61989 | $0.00 | 61,989.0000 | 0 | 9999.99% | 0.00% |
| Jan. 19, 2024 | HERON THERAPEUTICS, INC. /DE/ | $HRTX | Forbes William P | EVP, Chief Development Officer | A | Employee Stock Option (Right to Buy) | 371935 | $0.00 | 371,935.0000 | 0 | 9999.99% | 0.00% |